- Benzinga•3 months ago
Gyrodyne, LLC (NASDAQ: GYRO ) revealed that its Board has declared a special cash dividend of $9.25 per share or $13.71 million. According to the company, the dividend consisted of net proceeds from the ...
- PR Newswire•3 months ago
ST. JAMES, N.Y., May 26, 2016 /PRNewswire/ -- Gyrodyne, LLC (NASDAQ: GYRO), an owner and manager of a diversified portfolio of real estate properties ("Gyrodyne"), announced today that its Board ...
- PR Newswire•4 months ago
Gyrodyne's predecessor, Gyrodyne Company of America, Inc. (the "Corporation") acquired Fairfax Medical Center on March 31, 2009 for a purchase price of $12.891 million (or $224 per square foot), of which $4.891 million was paid in cash and $8 million was financed. The acquisition of this property qualified for the deferral treatment under Section 1033 of the Internal Revenue Code and completed the tax-efficient reinvestment of the $26.3 million advance payment received in connection with the condemnation of 245 acres of Gyrodyne's Flowerfield property. The balance of the mortgage loan was prepaid in full in December 2012 and assumed by a subsidiary of the Corporation which was settled in full as part of the August 31, 2015 merger of the Corporation and Gyrodyne Special Distribution, LLC into Gyrodyne.
Gyrodyne, LLC (GYRO)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Ask||20.50 x 200|
|Day's Range||20.04 - 20.04|
|52wk Range||19.76 - 33.76|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||53.02|
|Avg Vol (3m)||5,819|
|Dividend & Yield||0.00 (0.00%)|